Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30709577 | 0.87 | NOTUM (0.36) | — | |
| SCHEMBL30709432 | 0.85 | TGFBR1 (0.34) | MEN1KMT2AMAPTMAPK1NPSR1 | |
| SCHEMBL30709519 | 0.85 | CYP11B1 (0.38) | MEN1CYP19A1 | |
| SCHEMBL30709221 | 0.81 | — | — | |
| SCHEMBL16139058 | 0.76 | MEN1 (0.32) | MEN1RAB9AKMT2A | |
| SCHEMBL17279564 | 0.76 | TSPO (0.35) | MEN1KMT2A | |
| SCHEMBL30709410 | 0.75 | MEN1 (0.38) | MEN1RAB9AKMT2A | |
| SCHEMBL13203035 | 0.74 | ACHE (0.39) | MEN1RAB9AKMT2ACYP19A1MAPT | |
| SCHEMBL16138925 | 0.74 | MEN1 (0.33) | MEN1RAB9AKMT2A | |
| SCHEMBL16284766 | 0.73 | CYP19A1 (0.39) | MEN1RAB9AKMT2ACYP19A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | MEN1 2193/4885RAB9A 3239/4885KMT2A 4367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.